Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Overview • Market size and forecast • Five forces analysis PART 05: Segmentation by end-users • Overview • Clinical and research laboratories • Pharmaceutical and biotechnology companies • Others PART 06: Segmentation by geography • Overview • Americas • EMEA • APAC PART 07: Decision framework PART 08: Drivers and challenges • Market drivers • Market challenges PART 09: Market trends • Increased focus on targeted cancer treatment • Rising demand in emerging markets • Transition from FISH to array-based technique PART 10: Vendor landscape • Competitive scenario • Investment opportunity PART 11: Key vendor analysis • Abbott Laboratories • Agilent Technologies • Bio-Rad Laboratories • Thermo Fisher Scientific • Other prominent vendors PART 12: Appendix • List of abbreviations List of Exhibits Exhibit 01: Molecular cytogenetics: Applications Exhibit 02: Global molecular cytogenetics market: Overview 2016-2021 Exhibit 03: Global molecular cytogenetics market 2016-2021 ($ millions) Exhibit 04: Five forces analysis Exhibit 05: Global molecular cytogenetics market: Segmentation by end-users 2016-2021 (% share) Exhibit 06: Global molecular cytogenetics market: Overview of segmentation by end-users Exhibit 07: Global molecular cytogenetics market by clinical and research laboratories 2016-2021 ($ millions) Exhibit 08: Global molecular cytogenetics market by pharmaceutical and biotechnology companies 2016-2021 ($ millions) Exhibit 09: Global molecular cytogenetics market by others 2016-2021 ($ millions) Exhibit 10: Number of hospitals in various countries 2014 Exhibit 11: Global molecular cytogenetics market: Segmentation by geography 2016-2021 (% share) Exhibit 12: Global molecular cytogenetics market: Overview of segmentation by geography Exhibit 13: Molecular cytogenetics market in Americas 2016-2021 ($ millions) Exhibit 14: Prevalence of cancer in US 2015 (millions) Exhibit 15: Molecular cytogenetics market in EMEA 2016-2021 ($ millions) Exhibit 16: Molecular cytogenetics market in APAC 2016-2021 ($ millions) Exhibit 17: Estimated investments in R&D by India and China 2010-2030 Exhibit 18: Preventive screening and diagnosis: Essential elements Exhibit 19: Advantages of FISH over conventional methods Exhibit 20: FISH and DMI: Comparison Exhibit 21: Investments in R&D in APAC and GDP contribution 2016 Exhibit 22: FISH, CGH, and array CGH: Comparative analysis Exhibit 23: Global molecular cytogenetics market: Investment potential Exhibit 24: Abbott Laboratories: Overview Exhibit 25: Abbott Laboratories: Strength analysis Exhibit 26: Abbott Laboratories: Strategy assessment Exhibit 27: Abbott Laboratories: Opportunity assessment Exhibit 28: Agilent Technologies: Overview Exhibit 29: Agilent Technologies: Strength analysis Exhibit 30: Agilent Technologies: Strategy assessment Exhibit 31: Agilent Technologies: Opportunity assessment Exhibit 32: Bio-Rad Laboratories: Overview Exhibit 33: Bio-Rad Laboratories: Strength analysis Exhibit 34: Bio-Rad Laboratories: Strategy assessment Exhibit 35: Bio-Rad Laboratories: Opportunity assessment Exhibit 36: Thermo Fisher Scientific: Overview Exhibit 37: Thermo Fisher Scientific: Strength analysis Exhibit 38: Thermo Fisher Scientific: Strategy assessment Exhibit 39: Thermo Fisher Scientific: Opportunity assessment

Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, Applied Spectral Imaging, Biological Industries, CytoTest, Cytognomix, F. Hoffmann-La Roche, Illumina, Leica Biosystems, MetaSystems, Oxford Gene Technology, PerkinElmer, and SciGene.